26
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The TRiC/CCT Chaperone Is Implicated in Alzheimer's Disease Based on Patient GWAS and an RNAi Screen in Aβ-Expressing Caenorhabditis elegans

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The human Aβ peptide causes progressive paralysis when expressed in the muscles of the nematode worm, C. elegans. We have exploited this model of Aβ toxicity by carrying out an RNAi screen to identify genes whose reduced expression modifies the severity of this locomotor phenotype. Our initial finding was that none of the human orthologues of these worm genes is identical with the genome-wide significant GWAS genes reported to date (the “white zone”); moreover there was no identity between worm screen hits and the longer list of GWAS genes which included those with borderline levels of significance (the “grey zone”). This indicates that Aβ toxicity should not be considered as equivalent to sporadic AD. To increase the sensitivity of our analysis, we then considered the physical interactors (+1 interactome) of the products of the genes in both the worm and the white+grey zone lists. When we consider these worm and GWAS gene lists we find that 4 of the 60 worm genes have a +1 interactome overlap that is larger than expected by chance. Two of these genes form a chaperonin complex, the third is closely associated with this complex and the fourth gene codes for actin, the major substrate of the same chaperonin.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

          It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid beta-peptide (Abeta) in plaques in brain tissue. According to the amyloid hypothesis, accumulation of Abeta in the brain is the primary influence driving AD pathogenesis. The rest of the disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between Abeta production and Abeta clearance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

            Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous studies; however, a large portion of the genetic risk for this disease remains unexplained. We conducted a large, two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry. In stage 1, we used genotyped and imputed data (7,055,881 SNPs) to perform meta-analysis on 4 previously published GWAS data sets consisting of 17,008 Alzheimer's disease cases and 37,154 controls. In stage 2, 11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10(-8)) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Alzheimer's disease: genes, proteins, and therapy.

              Rapid progress in deciphering the biological mechanism of Alzheimer's disease (AD) has arisen from the application of molecular and cell biology to this complex disorder of the limbic and association cortices. In turn, new insights into fundamental aspects of protein biology have resulted from research on the disease. This beneficial interplay between basic and applied cell biology is well illustrated by advances in understanding the genotype-to-phenotype relationships of familial Alzheimer's disease. All four genes definitively linked to inherited forms of the disease to date have been shown to increase the production and/or deposition of amyloid beta-protein in the brain. In particular, evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics. The finding that presenilin itself may be the long-sought gamma-secretase, coupled with the recent identification of beta-secretase, has provided discrete biochemical targets for drug screening and development. Alternate and novel strategies for inhibiting the early mechanism of the disease are also emerging. The progress reviewed here, coupled with better ability to diagnose the disease early, bode well for the successful development of therapeutic and preventative drugs for this major public health problem.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2014
                31 July 2014
                : 9
                : 7
                : e102985
                Affiliations
                [1 ]Department of Genetics, University of Cambridge, Cambridge, United Kingdom
                [2 ]Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
                [3 ]Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom
                [4 ]MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
                [5 ]Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
                [6 ]Cambridge Systems Biology Centre, University of Cambridge, Cambridge, United Kingdom
                [7 ]Department of Medicine, University of Cambridge, Cambridge, United Kingdom
                [8 ]Department of Psychiatry and Neurology, MRC Centre for Neuropsychiatric Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom
                [9 ]The Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
                [10 ]Department of Medicine, University College London, London, United Kingdom
                National Center for Geriatrics and Gerontology, Japan
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Conceived and designed the experiments: DAL DBS DCC. Performed the experiments: AM DCC DBS. Analyzed the data: EK SJM JW SGO GF DCC. Wrote the paper: EK AM GF DCC. Read the manuscript and gave feedback: EK AM SJM JW DAL SGO GF DBS DCC.

                ¶ These authors also contributed equally to this work.

                Article
                PONE-D-14-05508
                10.1371/journal.pone.0102985
                4117641
                25080104
                a1b1c72f-3b67-4877-b5f0-a8165f3c63cc
                Copyright @ 2014

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 5 February 2014
                : 25 June 2014
                Page count
                Pages: 13
                Funding
                The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AM & JW were supported by Alzheimer’s Research UK ( http://www.alzheimersresearchuk.org). DCC was supported by an Alzheimer’s Research UK Senior Research Fellowship ( http://www.alzheimersresearchuk.org, grant code: ART-SRF2010-2) and the MRC ( http://www.mrc.ac.uk) and EPSRC ( http://www.epsrc.ac.uk/), UK (grant code: G0700990). SJM is supported by the MRC, UK ( http://www.mrc.ac.uk, grant code: G0601840). JW was supported by the MRC, UK ( http://www.mrc.ac.uk, grant codes: G0300429 and G0902227) and the Wellcome Trust ( http://www.wellcome.ac.uk, grant code: 082604/2/07/Z). DAL was supported by the MRC, UK ( http://www.mrc.ac.uk, grant code: G0901786) and the NIHR UCLH BRC ( http://www.uclhospitals.brc.nihr.ac.uk). DCC, DAL, GF, and SGO are all co-investigators on the Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative ( http://www.wellcome.ac.uk, grant code: WT089703AIA).
                Categories
                Research Article
                Biology and Life Sciences
                Computational Biology
                Genome Analysis
                Genome-Wide Association Studies
                Gene Regulatory Networks
                Computational Neuroscience
                Genetics
                Gene Identification and Analysis
                Genetic Screens
                Genetics of Disease
                Genomics
                Human Genetics
                Molecular Genetics
                Organisms
                Animals
                Invertebrates
                Nematoda
                Caenorhabditis
                Caenorhabditis Elegans
                Neuroscience
                Systems Biology
                Medicine and Health Sciences
                Mental Health and Psychiatry
                Dementia
                Alzheimer Disease
                Neurology
                Neurodegenerative Diseases
                Research and Analysis Methods
                Model Organisms
                Animal Models

                Uncategorized
                Uncategorized

                Comments

                Comment on this article